FAM188A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.943030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.631600E-01
Normal-vs-Stage2
1.341790E-01
Normal-vs-Stage3
1.374390E-02
Normal-vs-Stage4
7.447800E-01
Stage1-vs-Stage2
3.663800E-01
Stage1-vs-Stage3
1.269820E-01
Stage1-vs-Stage4
4.813800E-01
Stage2-vs-Stage3
2.390600E-01
Stage2-vs-Stage4
1.240040E-01
Stage3-vs-Stage4
5.159100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.032800E-01
Normal-vs-AfricanAmerican
3.599700E-02
Normal-vs-Asian
3.122200E-01
Caucasian-vs-AfricanAmerican
3.097800E-01
Caucasian-vs-Asian
8.131200E-01
AfricanAmerican-vs-Asian
5.551400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.460200E-01
Normal-vs-Female
2.695400E-01
Male-vs-Female
5.320200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.879800E-01
Normal-vs-Age(41-60Yrs)
3.575800E-01
Normal-vs-Age(61-80Yrs)
1.646440E-01
Normal-vs-Age(81-100Yrs)
3.838000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.277000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.536800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.919200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.461700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.394630E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.659800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.166640E-01
Normal-vs-Daily Drinker
7.388200E-02
Normal-vs-Weekly Drinker
3.754600E-01
Normal-vs-Occasional Drinker
5.088400E-01
Normal-vs-Social Drinker
4.351000E-01
Non Drinker-vs-Daily Drinker
7.133600E-01
Non Drinker-vs-Weekly Drinker
5.229200E-01
Non Drinker-vs-Occasional Drinker
1.741020E-01
Non Drinker-vs-Social Drinker
5.301800E-01
Daily Drinker-vs-Weekly Drinker
3.812000E-01
Daily Drinker-vs-Occasional Drinker
1.161150E-01
Daily Drinker-vs-Social Drinker
4.005400E-01
Weekly Drinker-vs-Occasional Drinker
6.290200E-01
Weekly Drinker-vs-Social Drinker
9.904600E-01
Occasional Drinker-vs-Social Drinker
6.540400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.600630E-01
Normal-vs-Grade 2
2.320400E-02
Normal-vs-Grade 3
9.143900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.598600E-01
Grade 1-vs-Grade 3
4.084800E-01
Grade 1-vs-Grade 4
1.600630E-01
Grade 2-vs-Grade 3
3.136000E-01
Grade 2-vs-Grade 4
2.320400E-02
Grade 3-vs-Grade 4
9.143900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.635600E-02
Normal-vs-NonDiabetic
1.940220E-01
Diabetic-vs-NonDiabetic
4.563600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.020300E-03
Normal-vs-NoPancreatitis
1.897240E-01
Pancreatitis-vs-NoPancreatitis
8.928100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.422400E-01
Normal-vs-N1
1.360590E-01
N0-vs-N1
2.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.752420E-01
Normal-vs-TP53-NonMutant
4.173400E-01
TP53-Mutant-vs-TP53-NonMutant
3.777200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
